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Diagnosis
Acute Flaccid Myelitis (AFM) awareness is expanding in pediatric 
intensive care units (PICU) around the world. The underlying 
etiology and protocols of management remain unclear to many 
medical professionals today. 
As of 2014, a correlation to the disease is associated with an 
enterovirus pathology. Unfortunately, its presentation can be 
easily missed and lead to detrimental outcomes. The paralysis 
seen in patients infected with Enterovirus-D68 is clinically defined 
as AFM, acute onset of paralysis with MRI scans showing neuron 
damage throughout the myelin (Cassidy, Poelman, Knoester, Van 
Leer-Buter, & Niesters, 2018). 
As new research continues to develop, the healthcare system and 
the Center for Disease Control (CDC) require a sustained pursuit 
to cure and prevent this devasting illness from affecting the lives 
of innocent children.
Acute Flaccid Myelitis Pathophysiology
AFM is a new, rare polio-like disease affecting the spinal cord gray 
matter; resulting in acute flaccid paralysis and weakness. 
Pathophysiology is unclear without the known cause. 
• Systemic inflammation is prevalent with spinal cord lesions 
starting at T2. 
• The first report of the disease in 2012 with a positive test of 
EDV68. In the subsequent years, many new cases have been 
reported in the late summer and fall (Jublet, 2019) 
• In most patients the etiology of AFM has not been verified, 
despite comprehensive lab research
• Whether the disease is a dire consequence of enterovirus D68 or 
other non-polio bacterial diseases or parainfectious immune 
responses remains uncertain  (Aliabadi et al., 2016) 
3 Phases of disease process 
1) Prodromal Illness
Ø Febrile illness 1-4 weeks prior to neurological
symptoms






2) Acute Neurologic Injury
Ø Rapid or prolonged – nadir 4 days
Ø Severity ranging from mild weakness to 
paralysis




Ø Flaccid paralysis or weakness of 
at least one limb
Ø Lung weakness
Ø Variable cranial nerve
involvement
3) Convalescent Phase
Ø Can range months-years
Ø Residual muscle 
weakness/atrophy
Ø Undetermined  complete 
recovery
(Fatemi & Chakraborty, 2019)
Diagnosis is difficult due to similar symptoms and presentation of other 
neurological diseases
q Acute onset of flaccid limb weakness 
q MRI findings of brain and spinal cord with grey matter involvement 
q Anterior horn cell involvement w/ spinal cord lesions at T2
q Lumbar Puncture-CSF sample
§ WBC>5u/mL
§ lymphocytic predominance
§ Variable protein levels
§ No glucose
q Respiratory PCR panel may detect enterovirus  
(Hopkins, 2019, and Wang & Greenberg, 2019)
Treatment and Nursing Implications 
❍ Supportive and symptomatic management of AFM
❍ Management of cardiovascular, respiratory, and autonomic
dysfunction depending on severity of disease
❍ Recommended supportive medicine includes:
o IV corticosteroid therapy to reduce systemic 
inflammation
o IV immunoglobulin (IVIG)
❍ Early initiation of physical and occupational therapy to prevent 
further weakness or contractures
❍ Long term treatment involves rehab and physical therapy
❍ Nursing
❍ Must be an advocate for the patient looking for 
signs of AFM
❍ Involvement with therapies
❍ Help collect specimens and diagnostic 
procedures
❍ Monitor for worsening symptoms
(Hopkins, 2019, and Wang & Greenberg, 2019)
The correlations/significance per Up to Date (Jublet, 2019) : 
●Enterovirus D68 was the most common virus detected in respiratory 
samples from children with AFM
●AFM cases clustered during periods of enterovirus D68 circulation in 2014 
to 2016 and were more sporadic when enterovirus D68 was not circulating 
in 2015
●Enterovirus D68 was detected in the blood of one child with AFM
●Metagenomic next-generation sequencing of cerebrospinal fluid from 14 
children with AFM did not find evidence of an alternative infectious cause
●Experimentally, contemporary enterovirus D68 strains cause paralytic 
myelitis in a mouse model
Key Points
AFM is a more and more acknowledged cause of paralysis that 
occurs mainly in kids.
⇢ No definite cause of AFM
⇢ Enteroviruses are the most common viral association 
⇢ Prevention is crucial 
⇢ Early recognition,  screening, and diagnosis needed for rapid 
treatment
⇢ 3 phases of disease process: Prodromal illness, acute 
neurological injury, convalescent phase 
⇢ Confirmed AFM is consistent with flaccid weakness, MRI 
findings, and CSF samples
⇢ Treatment is mainly supportive and symptomatic management
⇢ Early therapies help prevent further weakness or deterioration 
⇢ Nurses must monitor and advocate for patient
⇢ Specialists are actively seeking the cause and the means of 
preventing and treating AFM
⇢ The CDC is actively trying to prevent and treat AFM 
⇢ Reporting suspected or confirmed cases  of AFM to the CDC is 
one way we can help stop the reoccurrence of the rare, but 
devastating disease 














(CDC Vital Signs, 2019) 
(Cabral, 2018)
